Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-02-04

Clinical Trial Update: Exploratory Safety and Effectiveness Evaluation of Pulsed Field Ablation (PFA) by Balloon Catheter With TRUPULSE Generator for Treatment of Paroxysmal Atrial Fibrillation (PAF) [NA]

View source ↗

Summary

A clinical trial evaluating pulsed field ablation for paroxysmal atrial fibrillation has been withdrawn from the registry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRUPULSE Pulsed Field Ablation System with balloon catheter

Snippet

Sponsor: Biosense Webster, Inc. | Conditions: Atrial Fibrillation | NA | Status: WITHDRAWN